BUDGETS
ACCESS TO YOUR TESTS
MY RESULTS
PROFESSIONAL ACCESS
Description
SAMPLE TYPE: SALIVA
1 hour before: Do not eat, chew gum, smoke, or brush your teeth.
Avoid samples containing blood
Rinse mouth with water just before sampling
RESULTS: 20 DAYS
Results delivered from sample reception
The GNT. Thrombophilia in saliva evaluates genetic variants associated with hemostasis alterations and thrombotic/hemorrhagic risk. It integrates the F2 (Prothrombin), F5 (Factor V Leiden), and MTHFR genes to offer a broad view of coagulation balance and support clinical decisions in prevention, hormonal or anticoagulant treatments.
Its objective is to identify the genetic predisposition to abnormal clot formation or bleeding and guide the therapeutic and preventive strategy (e.g., choice of contraceptives, perioperative prophylaxis, pregnancy management).
- Identify predisposition to thrombosis (DVT/PE) or hemorrhagic tendency.
- Selection and adjustment of contraceptives and/or anticoagulants in people at risk.
- Studies of recurrent gestational losses and pregnancy complications.
- Personal or family history of early/recurrent thrombosis.
- Pre-surgical assessment or before prolonged immobilization, long trips, or major surgery.
- Integration into hereditary thrombophilia studies and cardiovascular prevention programs.
- FII [G20210A] (prothrombin)
- FV Leiden [G1691A] (proaccelerin)
- MTHFR [C677T and A1298C]
For more information, contact the Teletest administration department at 932 12 33 45 or through the following form
